VolitionRX Ltd (VNRX): Next-Year EPS Estimate 62.15%
As of 2026-10-16, VolitionRX Ltd (VNRX) has a next-year EPS growth estimate of 62.15%. Featured in our EPS revision report on 2026-05-25.
On 2026-09-16, analyst consensus for VNRX's next-year EPS growth shifted from 64.01% to 62.15% — a negative change of 1.86 percentage points. The revised estimate has been sustained across 29 subsequent trading sessions. Current-year growth is projected at 55.97%.
What's Driving This
VNRX has been rising primarily after analysts raised the next-year EPS growth estimate from 47.14% to 60.32% on 2026-08-18, a 13.
Generated 2026-10-13 from news as of 2026-10-13
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 62.15%
- EPS growth this year
- 55.97%
- EPS next quarter (est)
- -$0.38
- Last price
- $0.18
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-16 | 62.15% | 55.97% | -$0.38 | $0.18 |
| 2026-10-15 | 62.15% | 55.97% | -$0.38 | $0.19 |
| 2026-10-14 | 62.15% | 55.97% | -$0.38 | $0.18 |
| 2026-10-13 | 62.15% | 55.97% | -$0.38 | $0.18 |
| 2026-10-12 | 62.15% | 55.97% | -$0.38 | $0.20 |
| 2026-10-11 | 62.15% | 55.97% | -$0.38 | $0.21 |
| 2026-10-10 | 62.15% | 55.97% | -$0.38 | $0.21 |
| 2026-10-09 | 62.15% | 55.97% | -$0.38 | $0.21 |
| 2026-10-08 | 62.15% | 55.97% | -$0.38 | $0.22 |
| 2026-10-07 | 62.15% | 55.97% | -$0.38 | $0.23 |
| 2026-10-06 | 62.15% | 55.97% | -$0.38 | $0.24 |
| 2026-10-05 | 62.15% | 55.97% | -$0.38 | $0.23 |
| 2026-10-04 | 62.15% | 55.97% | -$0.38 | $0.23 |
| 2026-10-03 | 62.15% | 55.97% | -$0.38 | $0.23 |
| 2026-10-02 | 62.15% | 55.97% | -$0.38 | $0.23 |
| 2026-10-01 | 62.15% | 55.97% | -$0.38 | $0.23 |
| 2026-09-30 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-29 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-28 | 62.15% | 55.97% | -$0.38 | $0.25 |
| 2026-09-27 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-25 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-24 | 62.15% | 55.97% | -$0.38 | $0.25 |
| 2026-09-23 | 62.15% | 55.97% | -$0.38 | $0.25 |
| 2026-09-22 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-21 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-20 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-18 | 62.15% | 55.97% | -$0.38 | $0.26 |
| 2026-09-17 | 62.15% | 55.97% | -$0.38 | $0.28 |
| 2026-09-16 | 62.15% | 55.97% | -$0.38 | $0.27 |
| 2026-09-15 | 64.01% | 53.69% | -$0.39 | $0.29 |
Reports Featuring VNRX
Recent News
- VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...GuruFocus.com
- VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...GuruFocus.com
- Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis TestingPR Newswire
- VolitionRX: Q4 Earnings SnapshotAssociated Press
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business UpdatePR Newswire
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business UpdatePR Newswire
- VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of EarningsGuruFocus.com
- VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of EarningsGuruFocus.com
- VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in BelgiumPR Newswire
- VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in BelgiumPR Newswire
Screen Performance
Aggregate stats across all 2082 tickers our top-EPS-revision screen has flagged over the past 198 days.
- Median return since detection
- -3.0%
- % of tickers in the green
- 43%
- Median return on winners
- +21.5%
- Large revisions captured
- 1886
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is VolitionRX Ltd's next-year EPS growth estimate?▾
As of 2026-10-16, VolitionRX Ltd (VNRX) has a next-year EPS growth estimate of 62.15%, based on analyst consensus.
When was the latest EPS estimate revision for VNRX?▾
The most recent revision occurred on 2026-09-16, when analysts adjusted the next-year EPS growth estimate from 64.01% to 62.15%.
What sector and industry does VolitionRX Ltd belong to?▾
VolitionRX Ltd operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VNRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. VolitionRX Ltd (VNRX) appears here because it was detected by our daily top-EPS-revision-performer screen.